Single User License
INR 161250
Site License
INR 322500
Corporate User License
INR 483750

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Thymus Carcinoma Global Clinical Trials Review, H1, 2015

Thymus Carcinoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2593CTIDB
  • |
  • Pages: 63
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Thymus Carcinoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Thymus Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Thymus Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thymus Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thymus Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Thymus Carcinoma 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by G7 Countries: Proportion of Thymus Carcinoma to Oncology Clinical Trials 12

Clinical Trials by Phase in G7 Countries 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Thymus Carcinoma to Oncology Clinical Trials 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Thymus Carcinoma 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Prominent Drugs 24

Clinical Trial Profiles 25

Clinical Trial Overview of Top Companies 25

Nerviano Medical Sciences S.r.l. 25

Clinical Trial Overview of Nerviano Medical Sciences S.r.l. 25

Clinical Trial Overview of Top Institutes / Government 26

National Cancer Institute 26

Clinical Trial Overview of National Cancer Institute 26

Duke University 27

Clinical Trial Overview of Duke University 27

Shanghai Chest Hospital 28

Clinical Trial Overview of Shanghai Chest Hospital 28

Korean Cancer Study Group 29

Clinical Trial Overview of Korean Cancer Study Group 29

Istituto Clinico Humanitas 30

Clinical Trial Overview of Istituto Clinico Humanitas 30

Indiana University 31

Clinical Trial Overview of Indiana University 31

Memorial Sloan Kettering Cancer Center 32

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 32

Georgetown University 33

Clinical Trial Overview of Georgetown University 33

Indiana University School of Medicine 34

Clinical Trial Overview of Indiana University School of Medicine 34

Valley Health System 35

Clinical Trial Overview of Valley Health System 35

Five Key Clinical Profiles 36

Appendix 61

Abbreviations 61

Definitions 61

Research Methodology 62

Secondary Research 62

About GlobalData 63

Contact Us 63

Disclaimer 63

Source 63

List of Figures

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Thymus Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Thymus Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Thymus Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Thymus Carcinoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10

Thymus Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Proportion of Thymus Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Thymus Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Thymus Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Thymus Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 15

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Thymus Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Thymus Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Thymus Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Thymus Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Thymus Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24

GlobalData Methodology 62

List of Tables

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Region, 2015* 6

Thymus Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Thymus Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Thymus Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Thymus Carcinoma Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Thymus Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Proportion of Thymus Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Thymus Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Thymus Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Thymus Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 15

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Thymus Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Thymus Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Thymus Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Thymus Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Thymus Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Thymus Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Thymus Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Thymus Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nerviano Medical Sciences S.r.l., 2015* 25

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 26

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 27

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Chest Hospital, 2015* 28

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Korean Cancer Study Group, 2015* 29

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Clinico Humanitas, 2015* 30

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2015* 31

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 32

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2015* 33

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 34

Thymus Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valley Health System, 2015* 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Thymus Carcinoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Thymus Carcinoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com